[1] Wieland SF,Chisari FV.Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol,2005,79:9369-9380.
[2] Cooper A,Tal G,Lider O,et al.Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol,2005,175:3165-3176.
[3] Lu HL,Liao F.Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication. J Imunol,2013,191:3264-3276.
[4] Sato S,Li K,Kameyama T,et al.The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity,2015,42:123-132.
[5] Hosel M,Quasdorff M,Wiegmann K,et al.Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology,2009,50:1773-1782.
[6] Williams JB,Huppner A,Mulrooney-Cousins PM,et al.Differential expression of Woodchuck Toll-like receptors 1-10 in distinct forms of infection and stages of hepatitis in experimental hepatitis B virus infection. Front Microbiol,2018,9:3007.
[7] Karimi-Googheri M, Arababadi MK.TLR3 plays significant roles against hepatitis B virus. Mol Biol Rep,2014,41:3279-3286.
[8] Chen Z,Cheng Y,Xu Y,et al.Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol,2008,128:400-408.
[9] Shahrakyvahed A,Sanchooli J,Sanadgol N,et al.TLR9:an important molecule in the fight against hepatitis B virus. Postgraduate Med J,2014,90:396-401.
[10] Tomasello E,Naciri K,Chelbi R,et al.Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection. EMBO Jl,2018,37:312-316.
[11] Visvanathan K,Skinner NA,Thompson AJ,et al.Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology,2007,45:102-110.
[12] Sitia G,Iannacone M,Aiolfi R,et al.Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog,2011,7:e1002061.
[13] Yao N,Wang X.In vitro immunomodulatory activity of oxymatrine on Toll-like receptor 9 signal pathway in chronic hepatitis B. Am J Chin Med,2014,42:1399-1410.
[14] Wu J,Lu M,Meng Z,et al.Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology,2007,46:1769-1778.
[15] Ting JP,Lovering RC,Alnemri ES,et al.The NLR gene family: a standard nomenclature. Immunity,2008,28 :285-287.
[16] Nosratabadi R,Alavian SM,Zare-Bidaki M,et al.Innate immunity related pathogen recognition receptors and chronic hepatitis B infection. Mol Immunol,2017,90:64-73.
[17] Zhao Q,Peng L,Huang W,et al.Rare inborn errors associated with chronic hepatitis B virus infection. Hepatology,2012,56:1661-1670.
[18] Askari A,Nosratabadi R,Khaleghinia M,et al.Evaluation of NLRC4,NLRP1,and NLRP3,as components of inflammasomes,in chronic hepatitis B virus-infected patients. Viral Immunol,2016,29:496-501.
[19] Yoshino H,Saitoh T,Kozakai M,et al.Effects of ionizing radiation on retinoic acid-inducible gene-I-like receptors. Biomed Rep,2015,3:59-62.
[20] Han Q,Hou Z,Yin C,et al.5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice. Antiviral Res,2019,161:36-45.
[21] Chen X,Qian Y,Yan F,et al.5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells. Eur J Pharmacol,2013,721:86-95.
[22] Isogawa M,Robek MD,Furuichi Y,et al.Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol,2005,79:7269-7272.
[23] Zhang B,Liu Y,Wang X,et al.TLR3 activation of hepatic stellate cell line suppresses HBV replication in HepG2 cells. Front Immunol,2018 9:2921.
[24] Lanford RE,Guerra B,Chavez D,et al.GS-9620,an oral agonist of Toll-like receptor-7,induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees. Gastroenterology,2013,144:1508-1517. |
